Effects of improved glycaemic control on calcium and magnesium homeostasis in type II diabetes.
about
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusRisk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusThe relationship between hypomagnesemia, metformin therapy and cardiovascular disease complicating type 2 diabetes: the Fremantle Diabetes StudyA structural equation model for assessment of links between changes in serum triglycerides, -urate, and -glucose and changes in serum calcium, -magnesium and -phosphate in type 2 diabetes and non-diabetes metabolismAcid-base and electrolyte disorders associated with the use of antidiabetic drugs.A patient presenting with symptomatic hypomagnesemia caused by metformin-induced diarrhoea: a case report.
P2860
Effects of improved glycaemic control on calcium and magnesium homeostasis in type II diabetes.
description
1988 nî lūn-bûn
@nan
1988 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Effects of improved glycaemic ...... meostasis in type II diabetes.
@ast
Effects of improved glycaemic ...... meostasis in type II diabetes.
@en
type
label
Effects of improved glycaemic ...... meostasis in type II diabetes.
@ast
Effects of improved glycaemic ...... meostasis in type II diabetes.
@en
prefLabel
Effects of improved glycaemic ...... meostasis in type II diabetes.
@ast
Effects of improved glycaemic ...... meostasis in type II diabetes.
@en
P2093
P2860
P356
P1476
Effects of improved glycaemic ...... meostasis in type II diabetes.
@en
P2093
P2860
P304
P356
10.1136/JCP.41.9.933
P407
P577
1988-09-01T00:00:00Z